We are live on ! Find out more
SBWIC

Schaper Benz & Wise Investment Counsel Portfolio holdings

AUM $1.5B
1-Year Est. Return 31.02%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+31.02%
3 Year Est. Return
+83.38%
5 Year Est. Return
+96.2%
10 Year Est. Return
+357.25%
AUM
$449M
AUM Growth
+$17.5M
Cap. Flow
-$14.4M
Cap. Flow %
-3.21%
Top 10 Hldgs %
30.29%
Holding
94
New
5
Increased
21
Reduced
52
Closed
2

Top Buys

Rank Stock Value
1
SO icon
Southern Company
SO
+$1.59M
2
ABT icon
Abbott
ABT
+$897K
3
ALTR
Altera Corp
ALTR
+$699K
4
CSCO icon
Cisco
CSCO
+$668K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$534K

Top Sells

Rank Stock Value
1
MOLXA
MOLEX INC CL-A
MOLXA
+$12.2M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.71M
3
ABBV icon
AbbVie
ABBV
+$489K
4
NBL
Noble Energy, Inc.
NBL
+$409K
5
BGS icon
B&G Foods
BGS
+$390K

Sector Composition

Rank Sector Weight
1 Technology 19.31%
2 Financials 18.62%
3 Healthcare 17.58%
4 Consumer Staples 7.29%
5 Communication Services 5.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
76
Coca-Cola
KO
$372B
$426K 0.09%
10,309
– –
UNP icon
77
Union Pacific
UNP
$174B
$370K 0.08%
4,400
– –
APA icon
78
APA Corp
APA
$14.2B
$358K 0.08%
+4,160
New +$370K
RDS.A
79
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$321K 0.07%
4,818
– –
VFC icon
80
VF Corp
VFC
$5.81B
$320K 0.07%
+5,459
New +$284K
META icon
81
Meta Platforms (Facebook)
META
$1.53T
$309K 0.07%
5,650
– –
BMO icon
82
Bank of Montreal
BMO
$127B
$288K 0.06%
4,313
-732
-15% -$49.8K
EMR icon
83
Emerson Electric
EMR
$91.7B
$267K 0.06%
3,800
– –
AMZN icon
84
Amazon
AMZN
$2.94T
$249K 0.06%
+12,500
New +$225K
BGS icon
85
B&G Foods
BGS
$277M
$248K 0.06%
7,300
-11,370
-61% -$390K
BMY icon
86
Bristol-Myers Squibb
BMY
$130B
$240K 0.05%
4,520
-300
-6% -$15.3K
CL icon
87
Colgate-Palmolive
CL
$73.6B
$235K 0.05%
3,600
– –
T icon
88
AT&T
T
$168B
$222K 0.05%
8,350
– –
Y
89
DELISTED
Alleghany Corp
Y
$222K 0.05%
556
– –
WTBA icon
90
West Bancorporation
WTBA
$496M
$199K 0.04%
12,600
– –
MOLX
91
DELISTED
MOLEX INC
MOLX
– –
-9,711
Closed -$374K
MOLXA
92
DELISTED
MOLEX INC CL-A
MOLXA
– –
-317,577
Closed -$12.2M
1 2 3
4

Similar funds

SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return

Schaper Benz & Wise Investment Counsel's Q4 2013 Portfolio in Review

As of Q4 2013, Schaper Benz & Wise Investment Counsel held 94 positions worth $449M, up 4.1% from $431M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Schaper Benz & Wise Investment Counsel withdrew a net $14.4M in Q4 2013, closing 2 positions and reducing 52 holdings. Its most notable exit was MOLEX INC CL-A, an estimated $12.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Schaper Benz & Wise Investment Counsel opened a new position in Southern Company worth $1.58M.

  • Schaper Benz & Wise Investment Counsel's largest Q4 2013 buy was Southern Company: 38,450 shares worth $1.58M.
  • Schaper Benz & Wise Investment Counsel added most to Abbott in Q4 2013, an estimated $897K increase.
  • Schaper Benz & Wise Investment Counsel's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $1.71M.
  • Schaper Benz & Wise Investment Counsel fully exited MOLEX INC CL-A in Q4 2013, selling an estimated $12.2M.
  • Schaper Benz & Wise Investment Counsel's ten largest holdings make up 30% of its $449M portfolio in Q4 2013.
  • Schaper Benz & Wise Investment Counsel opened 5 new positions and closed 2 in Q4 2013.
  • Schaper Benz & Wise Investment Counsel's portfolio value rose 4.1% quarter-over-quarter to $449M.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q4 2013, filed 31 Jan 2014.